blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0237202

EP0237202 - Novel renin inhibiting peptides having a dihydroxyethylene isostere transition state insert [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.09.1993
Database last updated on 29.06.2024
Most recent event   Tooltip07.07.2007Change - inventorpublished on 08.08.2007  [2007/32]
Applicant(s)For all designated states
THE UPJOHN COMPANY
301 Henrietta Street Kalamazoo
Michigan 49001 / US
[N/P]
Former [1987/38]For all designated states
THE UPJOHN COMPANY
301 Henrietta Street
Kalamazoo, Michigan 49001 / US
Inventor(s)01 / Thaisrivongs, Suvit
c/o The Upjohn Company 301 Henrietta Street
Kalamazoo Michigan 49001 / US
[1987/38]
Representative(s)Perry, Robert Edward, et al
Gill Jennings & Every LLP The Broadgate Tower
20 Primrose Street
London
EC2A 2ES / GB
[N/P]
Former [1987/38]Perry, Robert Edward, et al
GILL JENNINGS & EVERY Broadgate House 7 Eldon Street
London EC2M 7LH / GB
Application number, filing date87301259.513.02.1987
[1987/38]
Priority number, dateUS1986083399327.02.1986         Original published format: US 833993
US1986090414905.09.1986         Original published format: US 904149
[1987/38]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0237202
Date:16.09.1987
Language:EN
[1987/38]
Type: A3 Search report 
No.:EP0237202
Date:19.11.1987
Language:EN
[1987/47]
Search report(s)(Supplementary) European search report - dispatched on:EP28.09.1987
ClassificationIPC:C07K5/02, C07D233/64, C07D401/12, // A61K31/415, A61K37/64 ,(C07D401/12, 213:00, 233:00)
[1987/38]
CPC:
C07D233/64 (EP); C07K5/02 (KR); C07K5/0227 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1991/22]
Former [1987/38]AT,  ES,  GR 
TitleGerman:Renin-inhibierende Peptide, die ein Dihydroxyethylen-Isoster des Übergangszustandes enthalten[1987/38]
English:Novel renin inhibiting peptides having a dihydroxyethylene isostere transition state insert[1987/38]
French:Inhibiteurs peptidiques de la rénine, contenant un isostère dihydroxyéthylène de l'état transitoire[1987/38]
File destroyed:12.06.1999
MiscellaneousEPB 1991/24: Verbunden mit 87901865.3/0406228 (europäische Anmeldenummer/Veröffentlichungsnummer) durch Entscheidung vom 30.04.91
EPB 1991/24: Consolidated with 87901865.3/0406228 (European application No./publication No.) by decision dated 30.04.91
EPB 1991/24: Jointe à la demande no. 87901865.3/0406228 (numéro de dépôt/numéro de publication de la demande européenne) par décision du 30.04.91
Examination procedure05.05.1988Examination requested  [1988/27]
11.09.1990Despatch of a communication from the examining division (Time limit: M04)
29.10.1990Reply to a communication from the examining division
13.09.1991Despatch of a communication from the examining division (Time limit: M08)
31.03.1992Reply to a communication from the examining division
07.04.1992Despatch of a communication from the examining division (Time limit: M06)
13.10.1992Reply to a communication from the examining division
16.12.1992Despatch of a communication from the examining division (Time limit: M04)
27.04.1993Application deemed to be withdrawn, date of legal effect  [1993/44]
03.06.1993Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1993/44]
Fees paidRenewal fee
28.02.1989Renewal fee patent year 03
22.01.1990Renewal fee patent year 04
18.01.1991Renewal fee patent year 05
15.01.1992Renewal fee patent year 06
13.01.1993Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]EP0128762  (SANKYO CO [JP]);
 [YD]EP0156322  (MERCK & CO INC [US]);
 [AD]EP0045665  (FERRING PHARMA LTD [GB], et al);
 [AD]EP0077028  (MERCK & CO INC [US]);
 [YP]EP0173481  (UPJOHN CO [US]);
 [YP]EP0189203  (ABBOTT LAB [US]);
 [YP]EP0184855  (ABBOTT LAB [US])
 [T]  - JOURNAL OF MEDICINAL CHEMISTRY, vol. 30, June 1987, pages 976-982, American Chemical Society, Washington, US; S. THAISRIVONGS et al.: "Renin inhibitors. Design of angiotensinogen transition-state analogues containing novel (2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.